What is Adhera Therapeutics?
Adhera Therapeutics, Inc. is a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes. The company is initially focused on commercializing PRESTALIA® (perindopril arginine and amlodipine besylate) through DyrctAxess, a patient-centric treatment approach. Our PRESTALIA product is approved by the US FDA for the treatment of hypertension to lower blood pressure. Adhera is dedicated to identifying additional assets to expand our commercial presence. Additional information can be found at http://www.adheratherapeutics.com.
Where is Adhera Therapeutics headquartered?
P.O. Box 2161
Wake Forest, NC 27588
Who are Adhera Therapeutics’ top executives?
Where is Adhera Therapeutics incorporated?
Adhera Therapeutics is incorporated in the State of Delaware.
When did Adhera Therapeutics go public?
Adhera Therapeutics went public in 1984 under the name “Nastech Pharmaceutical Company” and changed its name to “Adhera Therapeutics” on October 9, 2018.
Where does Adhera Therapeutics trade and what is the ticker symbol?
Adhera Therapeutics’ common stock is traded on the OTCQB under the symbol “ATRX”
When are quarterly financial results announced and how can I stay informed?
All events will be reported on this site within the time frame allotted by the SEC (45 days from the end of the quarter; 90 days from the end of the fiscal year December 31st), unless announced otherwise. Please see the event page for more information.
How do I invest in Adhera Therapeutics?
If you would like to purchase shares in Adhera Therapeutics, please contact your broker.
What is Adhera Therapeutics’ fiscal year?
Adhera Therapeutics’ fiscal year ends on December 31.
Who is Adhera Therapeutics’ transfer agent?
The transfer agent and registrar for the company’s common stock is:
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Does Adhera Therapeutics pay a dividend?
No, Adhera Therapeutics does not pay a dividend.
Does Adhera Therapeutics offer a Direct Stock Purchase Plan?
No, Adhera Therapeutics does not offer a Direct Stock Purchase Plan.
Who are Adhera Therapeutics’ independent auditors?
Squar Milner LLP.